The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Valneva’s single-dose chikungunya vaccine for use ...
Another child exhibiting symptoms of Guillain-Barre Syndrome (GBS) has been admitted to a hospital in Ranchi, bringing the total number of suspected cases in Jharkhand to three. While two children are ...
Hosted on MSN19h
Valneva’s chikungunya vaccine wins UK approvalValneva’s chikungunya vaccine Ixchiq has been greenlit by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) ...
Valneva (VALN) stock gained as its chikungunya vaccine receives marketing authorization in the U.K., expanding the single-dose shot's global reach. Read more here.
The world’s first chikungunya vaccine, developed by French pharmaceutical firm Valneva SE, has been approved in the UK by the ...
The world’s first vaccine for mosquito-borne chikungunya virus has been approved by the UK’s Medicines and Healthcare ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 4 February 2025, approved the vaccine chikungunya vaccine (live) (brand name ...
Le nombre de cas de chikungunya augmente fortement à La Réunion. Du 20 au 26 janvier, 169 nouveaux cas ont été signalés, ...
La propagation du Chikungunya se poursuit à La Réunion. Plusieurs foyers sont encore actifs sur l’île. Du 20 au 26 janvier, 169 nouveaux cas ont été enregistrés.
At least five suspected cases of chikungunya were recorded in Davao City in January 2025. The residents who were suspected of ...
Sri Lanka is experiencing a rise in Chikungunya cases, with the highest number of infections being reported across the ...
While much of Valneva's focus these days is centered on its landmark vaccine for chikungunya virus, the French immunization specialist's catalog of older shots continues to serve up fresh governmen | ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback